| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.025 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |